在ccl4诱导的肝纤维化中,芍药苷通过NF- B/HIF-1α通路调节巨噬细胞极化,减轻肝脏炎症和纤维化。

IF 4.8 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE American Journal of Chinese Medicine Pub Date : 2023-01-01 DOI:10.1142/S0192415X2350057X
Yang Liu, Chun-Yu He, Xue-Mei Yang, Wei-Cong Chen, Ming-Jia Zhang, Xiao-Dan Zhong, Wei-Guang Chen, Bing-Lian Zhong, Song-Qi He, Hai-Tao Sun
{"title":"在ccl4诱导的肝纤维化中,芍药苷通过NF- B/HIF-1α通路调节巨噬细胞极化,减轻肝脏炎症和纤维化。","authors":"Yang Liu,&nbsp;Chun-Yu He,&nbsp;Xue-Mei Yang,&nbsp;Wei-Cong Chen,&nbsp;Ming-Jia Zhang,&nbsp;Xiao-Dan Zhong,&nbsp;Wei-Guang Chen,&nbsp;Bing-Lian Zhong,&nbsp;Song-Qi He,&nbsp;Hai-Tao Sun","doi":"10.1142/S0192415X2350057X","DOIUrl":null,"url":null,"abstract":"<p><p>Liver fibrosis is a disease largely driven by resident and recruited macrophages. The phenotypic switch of hepatic macrophages can be achieved by chemo-attractants and cytokines. During a screening of plants traditionally used to treat liver diseases in China, paeoniflorin was identified as a potential drug that affects the polarization of macrophages. The aim of this study was to evaluate the therapeutic effects of paeoniflorin in an animal model of liver fibrosis and explore its underlying mechanisms. Liver fibrosis was induced in Wistar rats via an intraperitoneal injection of CCl<sub>4</sub>. In addition, the RAW264.7 macrophages were cultured in the presence of CoCl<sub>2</sub> to simulate a hypoxic microenvironment of fibrotic livers <i>in vitro</i>. The modeled rats were treated daily with either paeoniflorin (100, 150, and 200[Formula: see text]mg/kg) or YC-1 (2[Formula: see text]mg/kg) for 8 weeks. Hepatic function, inflammation and fibrosis, activation of hepatic stellate cells (HSC), and extracellular matrix (ECM) deposition were assessed in the <i>in vivo</i> and <i>in vitro</i> models. The expression levels of M1 and M2 macrophage markers and the NF-[Formula: see text]B/HIF-1[Formula: see text] pathway factors were measured using standard assays. Paeoniflorin significantly alleviated hepatic inflammation and fibrosis, as well as hepatocyte necrosis in the CCl<sub>4</sub>-induced fibrosis model. Furthermore, paeoniflorin also inhibited HSC activation and reduced ECM deposition both <i>in vivo</i> and <i>in vitro</i>. Mechanistically, paeoniflorin restrained M1 macrophage polarization and induced M2 polarization in the fibrotic liver tissues as well as in the RAW264.7 cells grown under hypoxic conditions by inactivating the NF-[Formula: see text]B/HIF-1[Formula: see text] signaling pathway. In conclusion, paeoniflorin exerts its anti-inflammatory and anti-fibrotic effects in the liver by coordinating macrophage polarization through the NF-[Formula: see text]B/HIF-1[Formula: see text] pathway.</p>","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 5","pages":"1249-1267"},"PeriodicalIF":4.8000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Paeoniflorin Coordinates Macrophage Polarization and Mitigates Liver Inflammation and Fibrogenesis by Targeting the NF-[Formula: see text]B/HIF-1α Pathway in CCl<sub>4</sub>-Induced Liver Fibrosis.\",\"authors\":\"Yang Liu,&nbsp;Chun-Yu He,&nbsp;Xue-Mei Yang,&nbsp;Wei-Cong Chen,&nbsp;Ming-Jia Zhang,&nbsp;Xiao-Dan Zhong,&nbsp;Wei-Guang Chen,&nbsp;Bing-Lian Zhong,&nbsp;Song-Qi He,&nbsp;Hai-Tao Sun\",\"doi\":\"10.1142/S0192415X2350057X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Liver fibrosis is a disease largely driven by resident and recruited macrophages. The phenotypic switch of hepatic macrophages can be achieved by chemo-attractants and cytokines. During a screening of plants traditionally used to treat liver diseases in China, paeoniflorin was identified as a potential drug that affects the polarization of macrophages. The aim of this study was to evaluate the therapeutic effects of paeoniflorin in an animal model of liver fibrosis and explore its underlying mechanisms. Liver fibrosis was induced in Wistar rats via an intraperitoneal injection of CCl<sub>4</sub>. In addition, the RAW264.7 macrophages were cultured in the presence of CoCl<sub>2</sub> to simulate a hypoxic microenvironment of fibrotic livers <i>in vitro</i>. The modeled rats were treated daily with either paeoniflorin (100, 150, and 200[Formula: see text]mg/kg) or YC-1 (2[Formula: see text]mg/kg) for 8 weeks. Hepatic function, inflammation and fibrosis, activation of hepatic stellate cells (HSC), and extracellular matrix (ECM) deposition were assessed in the <i>in vivo</i> and <i>in vitro</i> models. The expression levels of M1 and M2 macrophage markers and the NF-[Formula: see text]B/HIF-1[Formula: see text] pathway factors were measured using standard assays. Paeoniflorin significantly alleviated hepatic inflammation and fibrosis, as well as hepatocyte necrosis in the CCl<sub>4</sub>-induced fibrosis model. Furthermore, paeoniflorin also inhibited HSC activation and reduced ECM deposition both <i>in vivo</i> and <i>in vitro</i>. Mechanistically, paeoniflorin restrained M1 macrophage polarization and induced M2 polarization in the fibrotic liver tissues as well as in the RAW264.7 cells grown under hypoxic conditions by inactivating the NF-[Formula: see text]B/HIF-1[Formula: see text] signaling pathway. In conclusion, paeoniflorin exerts its anti-inflammatory and anti-fibrotic effects in the liver by coordinating macrophage polarization through the NF-[Formula: see text]B/HIF-1[Formula: see text] pathway.</p>\",\"PeriodicalId\":50814,\"journal\":{\"name\":\"American Journal of Chinese Medicine\",\"volume\":\"51 5\",\"pages\":\"1249-1267\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Chinese Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1142/S0192415X2350057X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Chinese Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1142/S0192415X2350057X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 1

摘要

肝纤维化是一种主要由常驻和募集的巨噬细胞驱动的疾病。肝巨噬细胞的表型转换可以通过化学引诱剂和细胞因子来实现。在筛选中国传统的用于治疗肝脏疾病的植物时,芍药苷被确定为一种影响巨噬细胞极化的潜在药物。本研究旨在评价芍药苷对肝纤维化动物模型的治疗作用,并探讨其作用机制。腹腔注射CCl4诱导Wistar大鼠肝纤维化。此外,在CoCl2存在下培养RAW264.7巨噬细胞,模拟体外纤维化肝脏的缺氧微环境。造模大鼠每天给予芍药苷(100、150和200[公式:见文]mg/kg)或YC-1(2[公式:见文]mg/kg) 8周。在体内和体外模型中评估肝功能、炎症和纤维化、肝星状细胞(HSC)活化和细胞外基质(ECM)沉积。采用标准法测定巨噬细胞M1、M2标记物及NF-[公式:见文]B/HIF-1通路因子的表达水平。芍药苷可显著减轻ccl4诱导的肝纤维化模型的肝脏炎症和纤维化,以及肝细胞坏死。此外,芍药苷在体内和体外均能抑制HSC的活化,减少ECM的沉积。在机制上,芍药苷通过灭活NF-[公式:见文]B/HIF-1[公式:见文]信号通路,抑制纤维化肝组织和缺氧条件下生长的RAW264.7细胞中的M1巨噬细胞极化,诱导M2极化。综上所述,芍药苷在肝脏中发挥抗炎抗纤维化作用是通过NF-[公式:见文]B/HIF-1[公式:见文]通路协调巨噬细胞极化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Paeoniflorin Coordinates Macrophage Polarization and Mitigates Liver Inflammation and Fibrogenesis by Targeting the NF-[Formula: see text]B/HIF-1α Pathway in CCl4-Induced Liver Fibrosis.

Liver fibrosis is a disease largely driven by resident and recruited macrophages. The phenotypic switch of hepatic macrophages can be achieved by chemo-attractants and cytokines. During a screening of plants traditionally used to treat liver diseases in China, paeoniflorin was identified as a potential drug that affects the polarization of macrophages. The aim of this study was to evaluate the therapeutic effects of paeoniflorin in an animal model of liver fibrosis and explore its underlying mechanisms. Liver fibrosis was induced in Wistar rats via an intraperitoneal injection of CCl4. In addition, the RAW264.7 macrophages were cultured in the presence of CoCl2 to simulate a hypoxic microenvironment of fibrotic livers in vitro. The modeled rats were treated daily with either paeoniflorin (100, 150, and 200[Formula: see text]mg/kg) or YC-1 (2[Formula: see text]mg/kg) for 8 weeks. Hepatic function, inflammation and fibrosis, activation of hepatic stellate cells (HSC), and extracellular matrix (ECM) deposition were assessed in the in vivo and in vitro models. The expression levels of M1 and M2 macrophage markers and the NF-[Formula: see text]B/HIF-1[Formula: see text] pathway factors were measured using standard assays. Paeoniflorin significantly alleviated hepatic inflammation and fibrosis, as well as hepatocyte necrosis in the CCl4-induced fibrosis model. Furthermore, paeoniflorin also inhibited HSC activation and reduced ECM deposition both in vivo and in vitro. Mechanistically, paeoniflorin restrained M1 macrophage polarization and induced M2 polarization in the fibrotic liver tissues as well as in the RAW264.7 cells grown under hypoxic conditions by inactivating the NF-[Formula: see text]B/HIF-1[Formula: see text] signaling pathway. In conclusion, paeoniflorin exerts its anti-inflammatory and anti-fibrotic effects in the liver by coordinating macrophage polarization through the NF-[Formula: see text]B/HIF-1[Formula: see text] pathway.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American Journal of Chinese Medicine
American Journal of Chinese Medicine 医学-全科医学与补充医学
CiteScore
9.90
自引率
8.80%
发文量
159
审稿时长
4.5 months
期刊介绍: The American Journal of Chinese Medicine, which is defined in its broadest sense possible, publishes original articles and essays relating to traditional or ethnomedicine of all cultures. Areas of particular interest include: Basic scientific and clinical research in indigenous medical techniques, therapeutic procedures, medicinal plants, and traditional medical theories and concepts; Multidisciplinary study of medical practice and health care, especially from historical, cultural, public health, and socioeconomic perspectives; International policy implications of comparative studies of medicine in all cultures, including such issues as health in developing countries, affordability and transferability of health-care techniques and concepts; Translating scholarly ancient texts or modern publications on ethnomedicine. The American Journal of Chinese Medicine will consider for publication a broad range of scholarly contributions, including original scientific research papers, review articles, editorial comments, social policy statements, brief news items, bibliographies, research guides, letters to the editors, book reviews, and selected reprints.
期刊最新文献
Acupuncture and Acupoints for Low Back Pain: Systematic Review and Meta-Analysis. Standardized Extract of Centella asiatica Prevents Fear Memory Deficit in 3xTg-AD Mice. Biometrics Data Visualization of Ginsenosides in Anticancer Investigations. 20(S)-Protopanaxadiol from Panax ginseng Induces Apoptosis and Autophagy in Gastric Cancer Cells by Inhibiting Src. Acupuncture for Fibromyalgia: A Review Based on Multidimensional Evidence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1